These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
149 related articles for article (PubMed ID: 6418650)
1. Is renin a factor in the etiology of essential hypertension? Haber E; Zusman R; Burton J; Dzau VJ; Barger AC Hypertension; 1983; 5(6 Pt 3):V8-15. PubMed ID: 6418650 [TBL] [Abstract][Full Text] [Related]
2. Inhibitors of renin: present and future. Haber E Clin Exp Hypertens A; 1983; 5(7-8):1193-205. PubMed ID: 6357563 [TBL] [Abstract][Full Text] [Related]
3. Will renin inhibitors influence decision-making in antihypertensive therapy? Haber E J Hypertens Suppl; 1985 Nov; 3(2):S71-80. PubMed ID: 3003303 [TBL] [Abstract][Full Text] [Related]
4. Peptide inhibitors of renin in cardiovascular studies. Haber E Fed Proc; 1983 Dec; 42(15):3155-61. PubMed ID: 6196232 [TBL] [Abstract][Full Text] [Related]
5. Defining the physiologic and pathophysiologic roles of renin: the role of specific inhibitors. Haber E Am J Kidney Dis; 1985 Apr; 5(4):A14-22. PubMed ID: 3887901 [TBL] [Abstract][Full Text] [Related]
6. The first Sir George Pickering memorial lecture. Which inhibitors will give us true insight into what renin really does? Haber E J Hypertens; 1984 Jun; 2(3):223-30. PubMed ID: 6099385 [TBL] [Abstract][Full Text] [Related]
7. Design, structure-activity, and molecular modeling studies of potent renin inhibitory peptides having N-terminal Nin-For-Trp (Ftr): angiotensinogen congeners modified by P1-P1' Phe-Phe, Sta, Leu psi[CH(OH)CH2]Val or leu psi[CH2NH]Val substitutions. Sawyer TK; Pals DT; Mao B; Staples DJ; de Vaux AE; Maggiora LL; Affholter JA; Kati W; Duchamp D; Hester JB J Med Chem; 1988 Jan; 31(1):18-30. PubMed ID: 3275777 [TBL] [Abstract][Full Text] [Related]
8. Inhibitors of the renin-angiotensin system as new antihypertensive agents. Antonaccio MJ Clin Exp Hypertens A; 1982; 4(1-2):27-46. PubMed ID: 6176373 [TBL] [Abstract][Full Text] [Related]
9. Pharmacological interferences with the renin-angiotensin system. Ganten D; Unger T; Lang RE Arzneimittelforschung; 1984; 34(10B):1391-8. PubMed ID: 6097263 [TBL] [Abstract][Full Text] [Related]
10. [Drugs and factors antagonizing the renin-angiotensin system]. Brus R Postepy Hig Med Dosw; 1983; 37(3):271-85. PubMed ID: 6369280 [No Abstract] [Full Text] [Related]
11. Design of rat renin inhibitory peptides. Hui KY; Holtzman EJ; Quinones MA; Hollenberg NK; Haber E J Med Chem; 1988 Sep; 31(9):1679-86. PubMed ID: 3045320 [TBL] [Abstract][Full Text] [Related]
13. On the specificity of human renin. Studies with peptide inhibitors. Poulsen K; Haber E; Burton J Biochim Biophys Acta; 1976 Dec; 452(2):533-7. PubMed ID: 1009126 [TBL] [Abstract][Full Text] [Related]
14. Why renin inhibitors? Haber E J Hypertens Suppl; 1989 Apr; 7(2):S81-6. PubMed ID: 2666619 [TBL] [Abstract][Full Text] [Related]
15. [Renin inhibition by peptides and pseudo-peptides]. Corvol P Nephrologie; 1989; 10(2):65-71. PubMed ID: 2677816 [TBL] [Abstract][Full Text] [Related]
16. Crystallographic studies of reduced bond inhibitors complexed with an aspartic proteinase. Foundling SI; Cooper J; Watson FE; Pearl LH; Hemmings A; Wood SP; Blundell T; Hallett A; Jones DM; Sueiras J J Cardiovasc Pharmacol; 1987; 10 Suppl 7():S59-68. PubMed ID: 2485065 [TBL] [Abstract][Full Text] [Related]